AMNIP · Five pillars · One compounding group
Five letters. One operating group.
AI · Media · Niseko · Investment · Precision Medicine. Each pillar compounds independently, and together they build something no single fund could.
AI Application
& Infrastructure.
95percent.ai, Screenbites, Project V, Project White House, and Project Re-Star. Building the infrastructure for the next generation of intelligence — multi-agent operating systems, AI-native economies, cinema-grade video generation, and AI-native gaming.
Portfolio includes
- 95percent.ai
- Screenbites
- Project VMulti-agent OS
- Project White HouseNiseko AI Economy
- Project Re-StarAI-native gaming
Media Content
& Distribution.
REMOW (Shueisha × Sumitomo), HuntMobi (US$680M revenue, Meta / Google / TikTok authorised), Lucky Dramas (5M+ downloads), and Star Girl (65M+ downloads). The global content and AdTech engine.
Portfolio includes
- REMOWShueisha × Sumitomo
- HuntMobiAdTech · US$680M revenue
- Lucky Dramas5M+ downloads
- Stargirl65M+ downloads
- Piano's ForestNetflix · NHK
- Ani-EyesAI anime production
Niseko Hospitality
& Real Estate.
The 1898 Niseko ultra-luxury hotel, a six-venue F&B portfolio, three large-scale developments (Ando Village, Niseko Riverside, Rusutsu), and a fully licensed real estate brokerage. A destination ecosystem at scale.
Portfolio includes
- The 1898 NisekoUltra-luxury hotel
- Ando Village50,000 sqm · Tadao Ando
- Niseko Riverside38,000 sqm riverside
- Rusutsu50–60 ski-in/ski-out villas
- Kutchan DowntownUrban mixed-use
- Yoteizanka FudosanLicensed brokerage
Investment VC
& Capital Markets.
Three PE funds totalling US$1.5B AUM. A track record spanning Legendary Pictures, Zoox (US$1.2B Amazon exit), Dave.com, and 50+ investments from seed to public markets across our global offices.
Portfolio includes
- AID Partners CapitalPE + VC
- Legendary PicturesUS$3.5B exit — Wanda, 2016
- ZooxUS$1.2B exit — Amazon, 2020
- DAVE Inc.NASDAQ: DAVE
- Prime Focus WorldVFX · US$250M
- Everest Venture GroupDigital asset studio
Precision Medicine
& Wellness.
Thai Omics (Thailand's national 80K WGS programme), AID Genomics (Israel molecular diagnostics), Nanyang Biologics (NASDAQ: NYB, Vecura™ AI drug discovery), and Project HBOC in Niseko. Controlling the genomic data layer across Southeast Asia and the Middle East.
Portfolio includes
- Thai OmicsNational genome centre
- AID GenomicsIsrael · molecular diagnostics
- Nanyang BiologicsNASDAQ: NYB · Vecura™
- Project HBOCNiseko longevity centre
- Genomics ThailandNational partner